Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)

NCT07629986 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis (CF)
Pulmonary Exacerbation
Respiratory Infection Bacterial

Interventions

OTHER: No intervention assigned

Sponsor

Fondation Ildys